A5078786319- Lung Cancer Research Studies
- Brain Metastases and Treatment
- Lung Cancer Treatments and Mutations
- Systemic Sclerosis and Related Diseases
- Sarcoidosis and Beryllium Toxicity Research
- Occupational and environmental lung diseases
- Cancer Genomics and Diagnostics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Radiomics and Machine Learning in Medical Imaging
- Glioma Diagnosis and Treatment
- Inflammatory Myopathies and Dermatomyositis
- Breast Implant and Reconstruction
Aix-Marseille Université
2020-2024
Hôpital Nord
2024
Assistance Publique Hôpitaux de Marseille
2020-2023
ABSTRACT Background Intracranial progression after curative treatment of early-stage non-small cell lung cancer (NSCLC) occurs from 10 to 50% and is difficult manage, given the heterogeneity clinical presentations variability treatments available. The objective this study was develop a mechanistic model intracranial predict survival following first brain metastasis (BM) event. Methods Data included NSCLC patients treated with intent who had BM as single relapse site (N=31). We propose...
Interstitial lung disease (ILD) is a known risk factor for cancer (LC). However, the surgical of LC in patients with ILD remains unclear. Therefore, we conducted single-center retrospective study to assess clinical features and outcome population who underwent surgery or without ILD. Patients between January 2006 June 2023 our center were assessed using data extracted from nationwide Epithor thoracic database. Suspicion was based on patients' records. Confirmation then made patient's medical...
Abstract Background: Intracranial progression after curative treatment of early-stage non-small cell lung cancer (NSCLC) occurs from 10 to 50% and is difficult manage, given the heterogeneity clinical presentations variability treatments available. The objective this study was develop a mechanistic model intracranial predict survival following first brain metastasis (BM) event. Methods: Data included NSCLC patients treated with intent who had BM as single relapse site (N=31). We propose...